Methodology

All entries for: GlaxoSmithKline LLC

December 4, 2025

GlaxoSmithKline LLC

Orphan Drug Designation

FDA orphan drug designation: treatment of small cell lung cancer

Disease Area: Rare Diseases
Source
Scroll to Top